封面
市场调查报告书
商品编码
1670850

2025 年 POC 测试全球市场报告

Point-of-Care Glucose Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年 POC 测试市场规模将强劲成长。到 2029 年,这一数字将成长至 65.1 亿美元,复合年增长率为 6.0%。预测期内的成长归因于远端医疗服务的扩展、对糖尿病治疗个人化医疗的日益重视、糖尿病管理计划的增加、对血糖测试研发的投资增加以及持续血糖监测的采用。预测期内的关键趋势包括穿戴式血糖监测设备的发展、智慧型手机连接在血糖测试中的整合、家庭医疗保健环境中就地检验的增长、人工智慧在血糖资料分析中的应用以及糖尿病远端患者监护的扩展。

糖尿病盛行率的不断上升预计将在未来几年推动 POC 检测市场的成长。糖尿病是一种慢性代谢性疾病,导致高血糖值并引发长期併发症,包括对心臟、血管、眼睛、肾臟和神经的严重损害。 POC 测试广泛用于监测住院患者的血糖浓度,能够根据血糖值的变化快速做出治疗决策,改善糖尿病管理和结果。例如,根据英国国民医疗服务体系 (NHS England) 2024 年 6 月的数据,英格兰被确诊为糖尿病前期的人数从 2022 年的 3,065,825 人增加到 2023 年的 3,615,330 人,增幅为 18%。此外,40 岁以下患者的数量将从 2022 年的 173,166 人增加到 2023 年的 216,440 人,增幅近 25%。因此,糖尿病盛行率的上升正在推动 POC 检测市场的成长。

人口老化加剧将进一步推动 POC 检测市场的成长。随着人口结构向老化转变,老年人口比例不断增加,POC 测试变得越来越重要。这项技术对老年人来说至关重要,特别是那些患有糖尿病风险高或已经被诊断出患有糖尿病的老年人。世界卫生组织(WHO)预测,到2030年,全球六分之一的人口将超过60岁。预计2020年全球60岁及以上人口比例将从10亿增至14亿,到2050年,全球60岁及以上人口预计将翻一番,达到21亿。因此,人口老化是 POC 检测市场的主要驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场:宏观经济情景,包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界 POC 考试 PESTEL 分析(政治、社会、技术、环境、法律、驱动因素、限制因素)
  • 最终用途产业分析
  • 全球 POC 测试市场:成长率分析
  • 全球 POC 测试市场表现:规模与成长,2019 年至 2024 年
  • 全球 POC 测试市场预测:规模与成长,2024-2029 年,2034 年预测
  • 全球 POC 测试总目标市场 (TAM)

第六章 市场细分

  • 全球 POC 测试市场:按产品、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 采血针和穿刺装置
  • 全球 POC 测试市场按测试地点、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 指尖
  • 替代站点测试
  • 全球 POC 测试市场:按应用、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 1 型糖尿病
  • 2 型糖尿病
  • 全球 POC 测试市场:按最终用户、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 专业诊断中心
  • 医院和诊所
  • 家庭护理设置
  • 其他最终用户
  • 全球 POC 检测市场,依产品细分,采血针和穿刺装置,绩效及预测,2019-2024 年,2024-2029 年,2034 年
  • 免稍后采血针
  • 多用途采血针
  • 可调式采血针装置
  • 全球 POC 测试市场,试纸细分市场,按产品、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 血糖试纸
  • 酮体试纸
  • 组合试纸(葡萄糖和酮体)
  • 全球 POC 测试市场,仪表细分产品、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 血糖值仪
  • 持续血糖监测(CGM)
  • 支援蓝牙的仪表

第七章 区域和国家分析

  • 全球 POC 测试市场:按地区、表现和预测,2019-2024 年、2024-2029 年、2034 年
  • 全球 POC 测试市场:按国家/地区、表现和预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章:义大利市场

第 20 章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章:加拿大市场

第26章 南美洲市场

第 27 章:巴西市场

第28章 中东市场

第 29 章:非洲市场

第 30 章竞争格局与公司概况

  • POC 测试市场:竞争格局
  • POC 测试市场:公司简介
    • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • TaiDoc Technology Corporation
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Nipro Corporation
  • Dexcom Inc.
  • Bio-Rad Laboratories Inc.
  • LifeScan Inc.
  • Nova Biomedical Corporation
  • Ypsomed AG
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health Inc.
  • Radiometer Medical ApS
  • HemoCue AB
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年 POC 检测市场:提供新机会的国家
  • 2029 年 POC 检测市场:细分市场将带来新机会
  • 2029 年 POC 测试市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r25220

Point-of-care glucose testing denotes a quality-assured pathology service administered in close proximity to the patient rather than within the conventional confines of a clinical laboratory. Clinicians or individuals employ small handheld units or glucose analyzers, along with testing strips, for glucose testing on whole blood. This approach reduces the duration from specimen collection to result verification, leading to swifter therapeutic intervention, diminished preanalytical errors, and enhanced patient care.

The primary components in point-of-care glucose testing encompass lancet and lancing devices, strips, and meters. Lancets, small sharp instruments, puncture the skin to extract a small blood drop for testing, while lancing devices securely hold the lancet and are activated with a simple button push. These devices facilitate straightforward blood withdrawal and assessment of blood glucose levels using a blood glucose monitor and test strips in point-of-care glucose testing. Testing sites include fingertips and alternate site testing, applied in both type-1 and type-2 diabetes. Various end-users, such as professional diagnostic centers, hospitals and clinics, home care settings, among others, utilize these methods.

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care glucose testing market statistics, including point-of-care glucose testing industry global market size, regional shares, competitors with a point-of-care glucose testing market share, detailed point-of-care glucose testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. This point-of-care glucose testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care glucose testing market size has grown steadily in recent years. It will grow from $4.91 billion in 2024 to $5.15 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to growing prevalence of diabetes, increased awareness of diabetes management, expansion of the aging population, rise in healthcare infrastructure, adoption of point-of-care testing

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $6.51 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to expansion of telemedicine services, growing emphasis on personalized medicine in diabetes care, rise in diabetes management programs, increased investment in glucose testing research and development, adoption of continuous glucose monitoring. Major trends in the forecast period include development of wearable glucose monitoring devices, integration of smartphone connectivity in glucose testing, growth of point-of-care testing in home healthcare settings, adoption of artificial intelligence in glucose data analysis, expansion of remote patient monitoring for diabetes.

The increasing prevalence of diabetes is expected to drive the growth of the point-of-care glucose testing market in the coming years. Diabetes is a chronic metabolic condition that raises blood glucose levels, leading to long-term complications, including severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is widely used to monitor glucose levels in hospitalized patients, enabling quick treatment decisions in response to changes in glycemia and improving diabetes management and therapeutic outcomes. For example, in June 2024, according to NHS England, the number of individuals identified with pre-diabetes in England rose to 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Moreover, cases among individuals under 40 surged by nearly 25%, from 173,166 in 2022 to 216,440 in 2023. Therefore, the rising prevalence of diabetes is fueling the growth of the point-of-care glucose testing market.

The growth of the point-of-care glucose testing market is further fueled by the rising aging population. As demographics shift toward an aging population, characterized by an increasing proportion of elderly individuals, point-of-care glucose testing becomes increasingly crucial. This technology serves essential purposes for older individuals, particularly those at higher risk of diabetes or already diagnosed. The World Health Organization projected that by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion, and by 2050, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion. Therefore, the growing aging population is a significant driver of the point-of-care glucose testing market.

Product innovation is a key trend gaining traction in the point-of-care glucose testing market, with major companies focused on developing innovative products. For instance, F. Hoffmann-La Roche AG introduced Cobas Pulse in January 2022, a new point-of-care blood glucose monitor designed for healthcare staff. This handheld device includes an automated glucose test strip reader, camera, and touchscreen, housed in a rugged casing that can be disinfected and used across all age groups, including newborns and intensive care patients. The innovation aims to enhance physicians' workflow by integrating Glucommander dosage software and offering downloadable decision-support apps.

Major companies in the point-of-care glucose testing market are also directing their efforts towards developing advanced solutions such as glucose-ketone monitoring sensors. Abbott Laboratories announced in June 2022 the development of a first-of-its-kind biowearable sensor system that continuously monitors glucose and ketones in diabetic patients. This breakthrough device, granted FDA designation, represents a significant advancement in regulatory status and is set to become the most compact and slender monitoring device globally. It integrates seamlessly with Abbott's digital ecosystem, allowing remote monitoring by healthcare professionals.

In August 2024, F. Hoffmann-La Roche AG, a healthcare company based in Switzerland, acquired Point of Care technology from LumiraDx Ltd. for an undisclosed sum. This acquisition enables Roche to enhance its diagnostics portfolio by incorporating a versatile platform that consolidates multiple tests into a single instrument, thereby supporting the growth of decentralized healthcare solutions. LumiraDx Ltd. is a UK-based company specializing in point-of-care diagnostics, particularly glucose testing solutions.

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

North America was the largest region in the point of care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care glucose testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care Glucose Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care glucose testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care glucose testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care glucose testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Lancet And Lancing Devices; Strips; Meters
  • 2) By Testing Site: Fingertips; Alternate Site Testing
  • 3) By Applications: Type-1 Diabetes; Type-2 Diabetes
  • 4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices
  • 2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)
  • 3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Danaher Corporation; Siemens Healthineers; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care Glucose Testing Market Characteristics

3. Point-of-Care Glucose Testing Market Trends And Strategies

4. Point-of-Care Glucose Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Point-of-Care Glucose Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-of-Care Glucose Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-of-Care Glucose Testing Market Growth Rate Analysis
  • 5.4. Global Point-of-Care Glucose Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-of-Care Glucose Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-of-Care Glucose Testing Total Addressable Market (TAM)

6. Point-of-Care Glucose Testing Market Segmentation

  • 6.1. Global Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lancet And Lancing Devices
  • Strips
  • Meters
  • 6.2. Global Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fingertips
  • Alternate Site Testing
  • 6.3. Global Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type-1 Diabetes
  • Type-2 Diabetes
  • 6.4. Global Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Professional Diagnostic Centers
  • Hospitals And Clinics
  • Home Care Settings
  • Other End Users
  • 6.5. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Lancet And Lancing Devices, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Lancets
  • Multi-Use Lancets
  • Adjustable Lancing Devices
  • 6.6. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Strips, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose Test Strips
  • Ketone Test Strips
  • Combo Strips (Glucose And Ketone)
  • 6.7. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Meters, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring (CGM) Meters
  • Bluetooth-Enabled Meters

7. Point-of-Care Glucose Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care Glucose Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-of-Care Glucose Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-of-Care Glucose Testing Market

  • 8.1. Asia-Pacific Point-of-Care Glucose Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-of-Care Glucose Testing Market

  • 9.1. China Point-of-Care Glucose Testing Market Overview
  • 9.2. China Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-of-Care Glucose Testing Market

  • 10.1. India Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-of-Care Glucose Testing Market

  • 11.1. Japan Point-of-Care Glucose Testing Market Overview
  • 11.2. Japan Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-of-Care Glucose Testing Market

  • 12.1. Australia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-of-Care Glucose Testing Market

  • 13.1. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-of-Care Glucose Testing Market

  • 14.1. South Korea Point-of-Care Glucose Testing Market Overview
  • 14.2. South Korea Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-of-Care Glucose Testing Market

  • 15.1. Western Europe Point-of-Care Glucose Testing Market Overview
  • 15.2. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-of-Care Glucose Testing Market

  • 16.1. UK Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-of-Care Glucose Testing Market

  • 17.1. Germany Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-of-Care Glucose Testing Market

  • 18.1. France Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-of-Care Glucose Testing Market

  • 19.1. Italy Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-of-Care Glucose Testing Market

  • 20.1. Spain Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-of-Care Glucose Testing Market

  • 21.1. Eastern Europe Point-of-Care Glucose Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-of-Care Glucose Testing Market

  • 22.1. Russia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-of-Care Glucose Testing Market

  • 23.1. North America Point-of-Care Glucose Testing Market Overview
  • 23.2. North America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-of-Care Glucose Testing Market

  • 24.1. USA Point-of-Care Glucose Testing Market Overview
  • 24.2. USA Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-of-Care Glucose Testing Market

  • 25.1. Canada Point-of-Care Glucose Testing Market Overview
  • 25.2. Canada Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-of-Care Glucose Testing Market

  • 26.1. South America Point-of-Care Glucose Testing Market Overview
  • 26.2. South America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-of-Care Glucose Testing Market

  • 27.1. Brazil Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-of-Care Glucose Testing Market

  • 28.1. Middle East Point-of-Care Glucose Testing Market Overview
  • 28.2. Middle East Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-of-Care Glucose Testing Market

  • 29.1. Africa Point-of-Care Glucose Testing Market Overview
  • 29.2. Africa Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-of-Care Glucose Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care Glucose Testing Market Competitive Landscape
  • 30.2. Point-of-Care Glucose Testing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Point-of-Care Glucose Testing Market Other Major And Innovative Companies

  • 31.1. TaiDoc Technology Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Nipro Corporation
  • 31.5. Dexcom Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. LifeScan Inc.
  • 31.8. Nova Biomedical Corporation
  • 31.9. Ypsomed AG
  • 31.10. Ascensia Diabetes Care Holdings AG
  • 31.11. Trividia Health Inc.
  • 31.12. Radiometer Medical ApS
  • 31.13. HemoCue AB
  • 31.14. EKF Diagnostics Holdings plc
  • 31.15. Trinity Biotech plc

32. Global Point-of-Care Glucose Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care Glucose Testing Market

34. Recent Developments In The Point-of-Care Glucose Testing Market

35. Point-of-Care Glucose Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Point-of-Care Glucose Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care Glucose Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care Glucose Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer